Alpha Teknova Statistics
NASDAQ: TKNOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
7.63-0.18 (-2.30%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Alpha Teknova by the numbers
Alpha Teknova has a market capitalization of $480.0 million based on 62.90M shares outstanding. With trailing EPS of $-0.30, Alpha Teknova is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.9% below its 50-day average and 45.2% above its 200-day average.
Average daily trading volume is 437.31K shares, or about $3.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TKNO valuation vs. peer median
| Metric | TKNO | Peer median | Difference |
|---|---|---|---|
| Market cap | $479.95M | $122.50M | +292% |
| Avg. volume | 437.31K | 821.95K | -47% |
Peer median across 8 companies: MYGN, QDEL, QUIT, NNNN, ICCC, IMDX, VNRX, TRIB.
Valuation
- Market cap
- $479.95M
- Price / sales (latest FY)
- 11.84
- EPS (TTM)
- $-0.30
- Shares outstanding
- 62.90M
Price and trading
- Previous close
- 7.81
- Open
- 7.63
- Day range
- 7.52 – 7.80
- 52-week range
- 1.91 – 9.48
- 52-week change
- +77.44%
- Beta
- —
- Volume
- 254.65K
- Average volume
- 437.31K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 479.95M
- Forward Pe
- -54.50
- Eps
- -0.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.48
- Week52 Low
- 1.91
- Avg Volume
- 437.31K
- Shares Outstanding
- 62.90M
- Ma50
- 7.94
- Ma200
- 5.26
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -19.51%
- Pct From52w Low
- 299.48%